Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergies

European Journal of Health Economics

Volumn 3, Issue 1, 2002, Pages 47-53

  Bridges, John F P ^a,b   Stewart, M ^c   King, M T ^d   Van Gool, K ^d  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Evaluation; Risk; Treatment synergies

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH ECONOMICS; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 0038621541     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-001-0090-5     Document Type: Article

References (26)

1. Hawe P, Shiell A (1995) Preserving innovation under increasing accountability pressures: the health promotion investment portfolio approach. Health Promotion J Aust 5:4-9
2. Bridges J, van Gool K, King M (2000) A cost-effectiveness analysis of nutrition interventions: first steps towards applying portfolio theory in public health. In Baldry J (ed) Economics and Health: 1999. Proceedings of the Twentieth Australian Conference of Health Economists, Australian Studies in Health Service Administration, no 87, pp 111-125
3. O'Brien B, Sculpher M (2000) Building uncertainty into cost-effectiveness rankings: portfolio risk-return trade-offs and implications for decision rules. Med Care 38:460-468
4. Drummond M, O'Brien B, Stoddart G, Torrance G (1997) Methods for the economic evaluation of health care programmes, 2nd edn. Oxford Medical: Oxford
5. Gold M, Siegel J, Russell L, Weinstein M (1996) Cost-effectiveness in health and medicine. Oxford University Press: New York
6. Lavori P, Dawson R (1998) Developing and comparing treatment strategies: an annotated portfolio of design. Psychopharmacol Bull 34:13-18
7. Kindig D (1988) Purchasing population health: aligning financial incentives to improving health outcome. Health Services Res 33:223-242
8. Allardice G, McMenamin J, Parpia T, Gibbs J, McSharry C, Whitelaw J (1998) The recent impact of antiretroviral therapy on CD4 counts, AIDS and death in HIV-infected persons: routine HIV surveillance in Scotland, Int J STD AIDS 9:561-566
9. Gurfinkel E, Manos E, Mejail R, Cerda M, Duronto E, Garcia C, Daroca A, Mautner B (1995) Low molecular weight aspirin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 26:313-318
10. Kok G, Hopsers H, den Boer D, de Vries H (1996) Health education at the individual level. In: Orth-Gomer K, Schneiderman N (eds) Behavioural medicine approaches to cardiovascular disease prevention. Erlbaum: New Jersey
11. Markowitz H (1952) Portfolio selection. J Finance 7:77-91
12. Brealey R, Myers S (1991) Principles of corporate finance, international edition, 4th edn. McGraw Hill: New York
13. Copland T, Weston J (1988) Financial theory and corporate policy, 3rd edn. Addison-Wesley: New York
14. Heckman J, Smith J (1995) Assessing the case for social experiments. J Econ Perspect 9:85-110
15. Graff Zivin J (2001) Cost-effectiveness analysis with risk aversion. Health Econ 10:499-508
16. Arrow K, Lind R (1970) Risk and uncertainty: uncertainty and the evaluation of public investment decisions. Am Econ Rev 60:364-378
17. Wakker P, Klaassen M (1995) Confidence intervals for cost/effectiveness ratios. Health Econ 4:373-381
18. Polsky D, Glick H, Willke R, Schulman K (1997) Confidence intervals for cost effectiveness ratios: a comparison of four methods. Health Econ 6:243-252
19. Briggs AH, Wonderling DE, Monney CZ (1997) Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 6:327-340
20. Hutubessy RC, Baltussen RM, Evans DB, Barendregt JJ, Murray CI (2001) Stochastic league tables: communicating cost-effectiveness results to decision makers. Health Econ 10:473-477
21. Briggs AH, Fenn P (1998) Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 7:723-740
22. Stinnett AA, Mullahy J (1998) Net health benefits: a new framework for the analysis of uncertainty in cost effectiveness analysis. Med Decis Making 18 [Suppl]:S68-S80
23. Sculpher M, Gafni A (2001) Recognising diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. Health Econ 10:317-324
24. Grossman M (1972) The demand for health: a theoretical and empirical investigation. NBER occasional paper 199. Columbia University Press: New York
25. Cook M (1951) Bi-variate k-statistics and cumulants of the joint sampling distribution. Biometrika 38:181
26. Kendall M, Stuart A, Ord J (1987) Kendall's advanced theory of statistics. Griffin